Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Vaccine-preventable diseases: the role of the European Centre for Disease Prevention and Control.

Kramarz P, Lopalco PL, Huitric E, Pastore Celentano L.

Clin Microbiol Infect. 2014 May;20 Suppl 5:2-6. doi: 10.1111/1469-0691.12430. Epub 2014 Jan 20. Review.

2.

Complete republication: Epidemiology of tuberculosis in the EU/EEA in 2010 - Monitoring the progress towards tuberculosis elimination.

Sandgren A, Hollo V, Huitric E, Ködmön C.

Eur J Microbiol Immunol (Bp). 2012 Dec;2(4):292-6. doi: 10.1556/EuJMI.2.2012.4.8. Epub 2012 Dec 11.

3.

Polio and the risk for the European Union.

Celentano LP, Lopalco PL, Huitric E, Coulombier D, Giesecke J.

Lancet. 2014 Jan 18;383(9913):216-7. doi: 10.1016/S0140-6736(13)62223-0. Epub 2013 Nov 14. No abstract available.

PMID:
24239251
4.

Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review.

Sandgren A, Schepisi MS, Sotgiu G, Huitric E, Migliori GB, Manissero D, van der Werf MJ, Girardi E.

Eur Respir J. 2014 Apr;43(4):1159-71. doi: 10.1183/09031936.00117213. Epub 2013 Oct 10. Review.

5.

Availability of anti-tuberculosis drugs in Europe.

Sotgiu G, D'Ambrosio L, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Lange C, Manissero D, Migliori GB.

Eur Respir J. 2012 Aug;40(2):500-3. doi: 10.1183/09031936.00009212. No abstract available.

6.

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones.

Migliori GB, Langendam MW, D'Ambrosio L, Centis R, Blasi F, Huitric E, Manissero D, van der Werf MJ.

Eur Respir J. 2012 Oct;40(4):814-22. Epub 2012 May 31. Review.

7.

Epidemiology of tuberculosis in the EU/EEA in 2010: monitoring the progress towards tuberculosis elimination.

Sandgren A, Hollo V, Huitric E, Kodmon C.

Euro Surveill. 2012 Mar 22;17(12). pii: 20124.

8.

European union standards for tuberculosis care.

Migliori GB, Zellweger JP, Abubakar I, Ibraim E, Caminero JA, De Vries G, D'Ambrosio L, Centis R, Sotgiu G, Menegale O, Kliiman K, Aksamit T, Cirillo DM, Danilovits M, Dara M, Dheda K, Dinh-Xuan AT, Kluge H, Lange C, Leimane V, Loddenkemper R, Nicod LP, Raviglione MC, Spanevello A, Thomsen VØ, Villar M, Wanlin M, Wedzicha JA, Zumla A, Blasi F, Huitric E, Sandgren A, Manissero D.

Eur Respir J. 2012 Apr;39(4):807-19. doi: 10.1183/09031936.00203811.

9.

TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?

Migliori GB, Sotgiu G, D'Ambrosio L, Centis R, Lange C, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Manissero D.

Eur Respir J. 2012 Mar;39(3):619-25. doi: 10.1183/09031936.00170411. Epub 2012 Feb 9.

10.

Knowledge of tuberculosis-treatment prescription of health workers: a systematic review.

van der Werf MJ, Langendam MW, Huitric E, Manissero D.

Eur Respir J. 2012 May;39(5):1248-55. doi: 10.1183/09031936.00125611. Epub 2011 Dec 19. Review.

11.

TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel?

Sotgiu G, D'Ambrosio L, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Lange C, Manissero D, Migliori GB.

Eur Respir J. 2011 Nov;38(5):1221-3. doi: 10.1183/09031936.00029311. No abstract available.

12.

Prevalence of inappropriate tuberculosis treatment regimens: a systematic review.

Langendam MW, van der Werf MJ, Huitric E, Manissero D.

Eur Respir J. 2012 Apr;39(4):1012-20. doi: 10.1183/09031936.00125511. Epub 2011 Oct 17. Review.

13.

Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis.

van der Werf MJ, Langendam MW, Huitric E, Manissero D.

Eur Respir J. 2012 Jun;39(6):1511-9. doi: 10.1183/09031936.00125711. Epub 2011 Oct 17. Review.

14.

The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results.

Kruijshaar ME, Pimpin L, Abubakar I, Rice B, Delpech V, Drumright LN, Hollo V, Huitric E, van de Laar M, Amato-Gauci A, Manissero D, Ködmön C.

Eur Respir J. 2011 Dec;38(6):1374-81. doi: 10.1183/09031936.00198310. Epub 2011 Jun 30.

15.

Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.

Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D.

Eur Respir J. 2011 Jan;37(1):88-99. doi: 10.1183/09031936.00115110. Epub 2010 Oct 28. Review. Erratum in: Eur Respir J. 2012 Mar;39(3):793.

16.

Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.

Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D.

Eur Respir J. 2011 Jan;37(1):100-11. doi: 10.1183/09031936.00114810. Epub 2010 Sep 16. Review. Erratum in: Eur Respir J. 2012 Mar;39(3):793.

17.

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.

Ködmön C, Hollo V, Huitric E, Amato-Gauci A, Manissero D.

Euro Surveill. 2010 Mar 18;15(11). pii: 19519.

18.
19.

Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor.

Huitric E, Verhasselt P, Koul A, Andries K, Hoffner S, Andersson DI.

Antimicrob Agents Chemother. 2010 Mar;54(3):1022-8. doi: 10.1128/AAC.01611-09. Epub 2009 Dec 28.

20.

In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor.

Huitric E, Verhasselt P, Andries K, Hoffner SE.

Antimicrob Agents Chemother. 2007 Nov;51(11):4202-4. Epub 2007 Aug 20.

21.

Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants.

Huitric E, Werngren J, Juréen P, Hoffner S.

Antimicrob Agents Chemother. 2006 Aug;50(8):2860-2.

22.

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V.

Science. 2005 Jan 14;307(5707):223-7. Epub 2004 Dec 9.

23.

[Methods for study of soluble antigens in pathological anatomy].

Laumonier R, Huitric E, Delpech A, Delpech B.

Ann Anat Pathol (Paris). 1976 Oct-Dec;21(4-5):413-38. French.

PMID:
1023784
24.

An optical and ultrastructural study of the localization of carcinoembryonic antigen (CEA) in normal and cancerous human rectocolonic mucosa.

Huitric E, Laumonier R, Burtin P, Von Kleist S, Chavanel G.

Lab Invest. 1976 Jan;34(1):97-107.

PMID:
1246127
25.

An ultrastructural study of the localization of the carcinoembryonic antigen in adenocarcinomas of the human colon.

Huitric E.

Ann Immunol (Paris). 1973 Nov;124(4):603-8. No abstract available.

PMID:
4792498

Supplemental Content

Loading ...
Support Center